LeonaBio (LONA) Operating Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Operating Expenses data on file, last reported at $17.2 million in Q1 2026.

• On a quarterly basis, Operating Expenses rose 815.64% year-over-year to $17.2 million in Q1 2026; TTM through Mar 2026 was $122.8 million, a 2.76% decrease from a year earlier, with the FY2025 full-year figure at $102.3 million, up 1.35% from the prior year.
• Operating Expenses for Q1 2026 stood at $17.2 million, down from $96.9 million in the prior quarter.
• Over the last five years, Operating Expenses for LONA reached as high as $96.9 million in Q4 2025 and fell as low as $1.8 million in Q2 2025.
• Historically, Operating Expenses has averaged $28.3 million across 5 years, with a median of $24.1 million in 2022.
• Across the five-year window, Operating Expenses sank 90.19% in 2024 and surged 815.64% in 2026, its largest moves.
• Year by year, Operating Expenses stood at $32.9 million in 2022, then slipped by 11.88% to $29.0 million in 2023, then jumped by 214.87% to $91.4 million in 2024, then grew by 6.06% to $96.9 million in 2025, then slumped by 82.23% to $17.2 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $17.2 million in Q1 2026, $96.9 million in Q4 2025, and $6.9 million in Q3 2025.